{
    "clinical_study": {
        "@rank": "45393", 
        "arm_group": [
            {
                "arm_group_label": "IABP group", 
                "arm_group_type": "Active Comparator", 
                "description": "After primary percutaneous coronary intervention, IABP will be implanted for 12-24 hours to alleviate persisting ischemia"
            }, 
            {
                "arm_group_label": "Control group", 
                "arm_group_type": "No Intervention", 
                "description": "After primary percutaneous coronary intervention, this group undergoes standard treatment according to the guidelines"
            }
        ], 
        "brief_summary": {
            "textblock": "Patients presenting with large myocardial infarction and signs of persistent ischemia after\n      successful percutaneous coronary intervention, have a poor prognosis with respect to outcome\n      and development of heart failure in the future.\n\n      The hypothesis of this study is that in patients in whom persistent ischemia is present, use\n      of intra-aortic balloon pump will be beneficial and improve outcome."
        }, 
        "brief_title": "Intra-aortic Balloon Pump in Extensive Myocardial Infarction With Persistent Ischemia", 
        "completion_date": {
            "#text": "July 2016", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Acute Myocardial Infarction", 
            "Persisting Ischemia", 
            "No Reflow"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Infarction", 
                "Ischemia", 
                "Myocardial Infarction"
            ]
        }, 
        "detailed_description": {
            "textblock": "In some patients presenting with large myocardial infarction and poor hemodynamic condition,\n      intra-aortic balloon counterpulsation is effective in alleviating cardiogenic shock. In\n      others, the use of intra-aortic balloon pump has no effect at all. The investigators believe\n      this is dependent on the presence of persisting ischemia after successful epicardial\n      reperfusion, known as no-reflow.\n\n      In the presence of persisting ischemia, the investigators believe us of the intra-aortic\n      balloon pump will relieve ischemia and improve outcome."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Acute ST-segment elevation myocardial infarction with summed ST-segment deviation \u226515\n             mm.\n\n          -  Insufficient ST-segment resolution (<50%) on the ECG made 10-30 minutes after the\n             primary PCI in the catheterization laboratory.\n\n        Exclusion Criteria:\n\n          -  Initial summed ST-segment deviation less than 15 mm\n\n          -  ST-segment resolution > 50% on the ECG performed in the catheterization laboratory\n\n          -  Chest pain onset less than 2 or more than 8 hours before arrival\n\n          -  Severe aortic valve stenosis/regurgitation\n\n          -  Aortic abnormalities prohibitive for use of intra aortic balloon pump\n\n          -  Full blown cardiogenic shock with immediate requirement of left ventricular assist\n             device as judged necessary by the operator\n\n          -  Inability to provide informed consent\n\n          -  Pregnancy\n\n          -  Inability to perform coronary angiography by the femoral approach"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "75 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "100", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "April 24, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02125526", 
            "org_study_id": "IABPinPI", 
            "secondary_id": "STW-11052"
        }, 
        "intervention": {
            "arm_group_label": "IABP group", 
            "description": "The intra-aortic balloon pump is placed in the descending thoracic aorta and inflates and deflates in synchrony with the cardiac cycle, providing diastolic augmentation and improving coronary blood flow, while deflating before systole, providing afterload and workload reduction for the myocardium.", 
            "intervention_name": "Intra-aortic balloon pump", 
            "intervention_type": "Device", 
            "other_name": [
                "IABP", 
                "Intra-aortic balloon counterpulsation"
            ]
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "keyword": [
            "Acute myocardial infarction", 
            "Persisting ischemia", 
            "No reflow", 
            "Intra-aortic balloon pump", 
            "Exhausted autoregulation"
        ], 
        "lastchanged_date": "April 30, 2014", 
        "location": {
            "contact": {
                "email": "lokien.v.nunen@cze.nl", 
                "last_name": "Lokien X van Nunen, MD", 
                "phone": "+31 40 2397004"
            }, 
            "contact_backup": {
                "email": "carias@cze.nl", 
                "last_name": "Ingrid Aarts", 
                "phone": "+31 402397004"
            }, 
            "facility": {
                "address": {
                    "city": "Eindhoven", 
                    "country": "Netherlands", 
                    "state": "Noord-Brabant", 
                    "zip": "5623EJ"
                }, 
                "name": "Catharina Hospital"
            }, 
            "investigator": [
                {
                    "last_name": "Nico HJ Pijls, MD PhD", 
                    "role": "Principal Investigator"
                }, 
                {
                    "last_name": "Lokien X van Nunen, MD", 
                    "role": "Sub-Investigator"
                }
            ], 
            "status": "Not yet recruiting"
        }, 
        "location_countries": {
            "country": "Netherlands"
        }, 
        "number_of_arms": "2", 
        "official_title": "Use of Intra-aortic Balloon Pump to Reduce Mortality in Extensive Myocardial Infarction With Persistent Ischemia; a Pilot Study", 
        "overall_contact": {
            "email": "carias@cze.nl", 
            "last_name": "Nico H.J. Pijls, MD PhD", 
            "phone": "+31 40 2397004"
        }, 
        "overall_contact_backup": {
            "email": "lokien.v.nunen@cze.nl", 
            "last_name": "Lokien X. van Nunen, MD", 
            "phone": "+31 40 2397004"
        }, 
        "overall_official": [
            {
                "affiliation": "Catharina Hospital Eindhoven", 
                "last_name": "Nico H.J. Pijls, MD PhD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Catharina Hospital Eindhoven", 
                "last_name": "Lokien X van Nunen, MD", 
                "role": "Principal Investigator"
            }
        ], 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "The Netherlands: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "measure": "Composite endpoint of mortality, necessity for mechanical support due to hemodynamic deterioration, and hospital admission for heart failure", 
                "safety_issue": "No", 
                "time_frame": "6 months"
            }, 
            {
                "measure": "All-cause mortality", 
                "safety_issue": "No", 
                "time_frame": "30 days and 6 months"
            }
        ], 
        "reference": {
            "PMID": "24170231", 
            "citation": "van Nunen LX, van 't Veer M, Schampaert S, Steerneman BJ, Rutten MC, van de Vosse FN, Pijls NH. Intra-aortic balloon counterpulsation in acute myocardial infarction: old and emerging indications. Neth Heart J. 2013 Dec;21(12):554-60. doi: 10.1007/s12471-013-0485-9."
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02125526"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Catharina Ziekenhuis Eindhoven", 
            "investigator_full_name": "Lokien van Nunen", 
            "investigator_title": "MD", 
            "responsible_party_type": "Sponsor-Investigator"
        }, 
        "source": "Catharina Ziekenhuis Eindhoven", 
        "sponsors": {
            "collaborator": [
                {
                    "agency": "Stichting Toegepaste Wetenschappen (project number 11052)", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Maquet Cardiovascular", 
                    "agency_class": "Industry"
                }
            ], 
            "lead_sponsor": {
                "agency": "Lokien van Nunen", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "July 2014", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "April 2014"
    }
}